Delivery Order SPE2DB20D2002-SPE2DB25FL45X
Award Date
5/28/25
Potential Completion Date
5/29/25
Potential Value
$2.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the diabetes medication Trulicity 1.5 mg/0.5 ml pen. The contract has a firm fixed price of $1,801.80 and a period of performance through April 17, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of the diabetes medication Trulicity 1.5 mg/0.5 ml pen. The contract has a firm fixed price of $2,179.11 and a period of performance through May 20, 2025. The contract is not set aside and was competed openly. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trulicity 1.5 mg/0.5 ml pen 0.5 ml, a diabetes medication. The contract has a firm fixed price of $3,967.20 and a completion date of April 21, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive...
This is a $1,511.67 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 0.75 mg/0.5 ml pens of the diabetes medication Trulicity, with a period of performance through May 29, 2025. The contract is not set aside and was awarded through open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Trulicity 3 mg/0.5 ml pens, a diabetes treatment medication. The contract has a firm fixed price, a ceiling value of $6,966.09, and a period of performance through April 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the diabetes medication Trulicity 1.5 mg/0.5 ml pen. The contract has a firm fixed price of $2,702.70 and a period of performance through April 16, 2025. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trulicity 1.5 mg/0.5 ml pens. The contract has a ceiling value of $1,801.80 and an ultimate completion date of January 17, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. The contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Trulicity 1.5 mg/0.5 ml pens, a medication used to treat diabetes. The contract has a ceiling value of $3,642.95 and is a firm fixed-price delivery order. The contract has an ultimate completion date of May 9, 2025. This appears to be part of a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 0.75 mg/0.5 ml Trulicity pens, a medication used to manage diabetes. The fixed-price contract has a ceiling value of $2,702.70 and an ultimate completion date of February 20, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,006.00, is for the supply of the diabetes medication Trulicity 3 mg/0.5 ml pen. The contract is a firm fixed-price delivery order, with a performance period extending through May 1, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating open competition. This contract is...